SAN FRANCISCO, CA—Administering low-dose alteplase directly into the artery prior to PCI in patients with STEMI and a large thrombus burden fails to lower the risk of a range of outcomes, including ...
Alteplase is the standard agent used in early reperfusion therapy, but alternative thrombolytic agents are needed. The efficacy and safety of reteplase as compared with alteplase in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results